表紙
市場調査レポート

MediFocus:世界の肥満治療用医療機器の市場

MediFocus: Medical Devices for the Treatment of Obesity

発行 GlobalData 商品コード 270723
出版日 ページ情報 英文 130 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
MediFocus:世界の肥満治療用医療機器の市場 MediFocus: Medical Devices for the Treatment of Obesity
出版日: 2013年05月15日 ページ情報: 英文 130 Pages
概要

肥満関連の外科手術技法は過去数十年間に大きく進展し、治療法のゴールドスタンダード(至適基準)と言える状態にまでなりましたが、肥満患者のわずか1%しか外科的介入を受けようとしていません。手術の低侵襲性が強まり、医療機器も近年急速に進化し、また世界各国で認証を得た技法も出てきましたが、長期的な有効性はまだ十分ではないため、継続的な開発と絶え間ない市場競争とが促進されていくことになります。

当レポートでは、全世界の肥満治療用の医療機器・技術市場について分析し、現在・将来の市場環境や、上市済み製品の概要と競争力、開発中の製品の概要と治験の進行状況、主要企業のプロファイルと競争力、専門家の見解などを調査して、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 市場概況

  • 背景事情
    • 過食と栄養不足
    • 製薬会社は肥満市場の掌握に失敗し、医療技術企業に付け入る隙を与える
    • 外科手術が現在でもゴールド・スタンダードである
    • 糖尿病の適応症が、肥満用医療機器業界の一層の成長を促す
    • 小児科での新たな適応症
    • 国際市場の成長
    • 高額の治療費と医療費償還制度の変化
    • 医療機器導入の促進要因

第4章 競争力の評価

  • 概要
  • 人工膨満装置
    • End Ball (Endalis Laboratory)
    • Obalon (Obalon Therapeutics)
    • Orbera (Allergan)
    • Heliosphere (Helioscopie)
    • ReShape Duo (ReShape Medical)
    • SatiSphere (EndoSphere)
    • Spatz 3 (Spatz Medical)
  • 内視鏡手術装置
    • Intraluminal Stapler (Ethicon)
    • OverStitch (Apollo Endosurgery)
    • StomaphyX (EndoGastric Solutions)
  • 胃電気刺激装置
    • Abiliti (IntraPace, Inc.)
    • DIAMOND Tantalus (MetaCure Inc.)
  • 胃内容排出・吸引装置
    • AspireAssist (Aspire Bariatrics, Inc.)
  • 吸収障害装置
    • EndoBarrier (GI Dynamics, Inc.)
  • 神経細胞ブロック技術
    • Vbloc Maestro System (EnteroMedics)
  • 胃拘束装置
    • AMI Band (Agency for Medical Innovation)
    • Bioring (Cousin Biotech)
    • Heliogast (Helioscopie)
    • Lap-Band (Allergan)
    • Midband (Medical Innovation Development)
    • MiniMizer Extra (Bariatric Solutions)
    • Swedish/Realize Band (Ethicon-Endosurgery)

第5章 パイプライン製品

  • 概要
  • 人工膨満装置
    • Full Sense Device (BFKW)
    • TransPyloric Shuttle (Baronova)
  • 脳深部刺激装置
    • Deep Brain Stimulation Device (NeuroSigma)
  • 内視鏡手術装置
    • ACE Stapler (BaroSense)
    • RS2 Restore (CR Bard)
  • 吸収障害装置
    • ValenTx (ValenTx)
  • 胃拘束装置
    • AMI B-Band (Agency for Medical Innovation)
    • AMI Basket (Agency for Medical Innovation)
    • TERIS (BaroSense, Inc.)

第6章 現在・将来の市場参入企業

  • 概要
    • ライフスタイルの問題に協力する機会を得た医療機器企業
  • 企業プロファイル(全24社)
    • Allergan
    • Apollo Endosurgery, Inc.
    • Aspire Bariatrics, Inc.
    • Agency for Medical Innovation
    • Bariatric Solutions
    • Baronova
    • BaroSense, Inc.
    • BFKW
    • Cousin Biotech
    • CR Bard
    • Endalis Laboratory
    • EndoGastric Solutions
    • EndoSphere, Inc.
    • EnteroMedics, Inc.
    • Ethicon Endo-Surgery
    • GI Dynamics
    • Helioscopie
    • IntraPace, Inc.
    • Medical Innovation Development
    • MetaCure Inc.
    • Obalon Therapeutics
    • ReShape Medical
    • Spatz Medical
    • ValenTx, Inc.

第7章 付録

図表一覧

目次
Product Code: GDME001MFR

Summary

The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement in recent decades, evolving to become the gold standard for proven treatment in the absence of effective pharmacotherapy, only 1% of obese patients opt for surgical intervention. Less-invasive that surgery, obesity treatment medical devices have seen notable advancement in recent years, and several technologies have gained international adoption; however, long-term efficacy is still lacking, prompting continued development and ever-changing market competition.

GlobalData has released its medical device report, "MediFocus: Medical Devices for the Treatment of Obesity". The report offers a comprehensive analysis of the global obesity medical device market, including development and approval of artificial fullness devices, deep brain stimulation devices, endoscopic surgical devices, gastric electrical stimulation devices, gastric emptying aspiration tools, malabsorption devices, neuronal blocking technology, and restrictive devices. Included within is an analysis of the pipeline and approved obesity treatment products, with a focus on safety, efficacy and commercial positioning, as well as an examination of companies currently active in the field. The report identifies and evaluates key trends and advances shaping the global obesity medical device market, highlighting testimonials from top physicians around the world who are already utilizing the devices, with a focus on next-generation technologies. The report provides insight into the competitive obesity medical device landscape, including new companies approaching commercialization and pipeline products in development. This report was built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of cardiovascular medical device experts.

Scope

  • An overview of the international obesity treatment medical device landscape
  • Investigation of current and future market competition for obesity medical devices
  • Competitive assessment with device strengths and weaknesses analyzed
  • Marketed and pipeline product profiles covering efficacy, safety, clinical study details, regulatory approvals, and commercial positioning
  • Evaluation of technology trends to assess pipeline product strength
  • Overview of all devices in development, including design considerations, efficacy reports, and physician perception
  • Coverage of key market players with portfolio assessment and SWOT analysis
  • Direct quotes from Key Opinion Leaders (KOL) currently using obesity medical devices

Reasons to buy

  • Understand the trends shaping and driving the obesity medical device markets
  • Realize device preferences of physicians who have performed dozens of implantations already
  • Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth
  • What's the next big thing in the global Obesity Medical Device market? Identify, understand and capitalize

Table of Contents

1. Table of Contents

  • 1.1. List of Tables

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Market Overview

  • 3.1. Background
    • 3.1.1. Overfed and Under-nurtured
    • 3.1.2. Pharma Fails to Seize the Obesity Market, Leaves Void for Med-Tech to Fill
    • 3.1.3. Surgery Remains the Gold Standard for Now
    • 3.1.4. Diabetes Indications Further Fuel Obesity Medical Device Industry Growth
    • 3.1.5. New Indications in Pediatrics
    • 3.1.6. International Market Growth
    • 3.1.7. High Costs and Evolving Reimbursement
    • 3.1.8. Drivers Behind Device Adoption

4. Competitive Assessment

  • 4.1. Overview
  • 4.2. Artificial Fullness Devices
    • 4.2.1. End Ball (Endalis Laboratory)
    • 4.2.2. Obalon (Obalon Therapeutics)
    • 4.2.3. Orbera (Allergan)
    • 4.2.4. Heliosphere (Helioscopie)
    • 4.2.5. ReShape Duo (ReShape Medical)
    • 4.2.6. SatiSphere (EndoSphere)
    • 4.2.7. Spatz 3 (Spatz Medical)
  • 4.3. Endoscopic Surgical Devices
    • 4.3.1. Intraluminal Stapler (Ethicon)
    • 4.3.2. OverStitch (Apollo Endosurgery)
    • 4.3.3. StomaphyX (EndoGastric Solutions)
  • 4.4. Gastric Electrical Stimulation
    • 4.4.1. Abiliti (IntraPace, Inc.)
    • 4.4.2. DIAMOND Tantalus (MetaCure Inc.)
  • 4.5. Gastric Emptying Aspiration Tools
    • 4.5.1. AspireAssist (Aspire Bariatrics, Inc.)
  • 4.6. Malabsorption Devices
    • 4.6.1. EndoBarrier (GI Dynamics, Inc.)
  • 4.7. Neuronal Blocking Technology
    • 4.7.1. Vbloc Maestro System (EnteroMedics)
  • 4.8. Restrictive Devices
    • 4.8.1. AMI Band (Agency for Medical Innovation)
    • 4.8.2. Bioring (Cousin Biotech)
    • 4.8.3. Heliogast (Helioscopie)
    • 4.8.4. Lap-Band (Allergan)
    • 4.8.5. Midband (Medical Innovation Development)
    • 4.8.6. MiniMizer Extra (Bariatric Solutions)
    • 4.8.7. Swedish/Realize Band (Ethicon-Endosurgery)

5. Pipeline Products

  • 5.1. Overview
  • 5.2. Artificial Fullness Devices
    • 5.2.1. Full Sense Device (BFKW)
    • 5.2.2. TransPyloric Shuttle (Baronova)
  • 5.3. Deep Brain Stimulation
    • 5.3.1. Deep Brain Stimulation Device (NeuroSigma)
  • 5.4. Endoscopic Surgical Devices
    • 5.4.1. ACE Stapler (BaroSense)
    • 5.4.2. RS2 Restore (CR Bard)
  • 5.5. Malabsorption Devices
    • 5.5.1. ValenTx (ValenTx)
  • 5.6. Restrictive Devices
    • 5.6.1. AMI B-Band (Agency for Medical Innovation)
    • 5.6.2. AMI Basket (Agency for Medical Innovation)
    • 5.6.3. TERIS (BaroSense, Inc.)

6. Current and Future Players

  • 6.1. Overview
    • 6.1.1. Medical Device Companies have Opportunity to Incorporate Lifestyle Programs
  • 6.2. Company Profiles
    • 6.2.1. Allergan
    • 6.2.2. Apollo Endosurgery, Inc.
    • 6.2.3. Aspire Bariatrics, Inc.
    • 6.2.4. Agency for Medical Innovation
    • 6.2.5. Bariatric Solutions
    • 6.2.6. Baronova
    • 6.2.7. BaroSense, Inc.
    • 6.2.8. BFKW
    • 6.2.9. Cousin Biotech
    • 6.2.10. CR Bard
    • 6.2.11. Endalis Laboratory
    • 6.2.12. EndoGastric Solutions
    • 6.2.13. EndoSphere, Inc.
    • 6.2.14. EnteroMedics, Inc.
    • 6.2.15. Ethicon Endo-Surgery
    • 6.2.16. GI Dynamics
    • 6.2.17. Helioscopie
    • 6.2.18. IntraPace, Inc.
    • 6.2.19. Medical Innovation Development
    • 6.2.20. MetaCure Inc.
    • 6.2.21. Obalon Therapeutics
    • 6.2.22. ReShape Medical
    • 6.2.23. Spatz Medical
    • 6.2.24. ValenTx, Inc.

7. Appendix

  • 7.1. Bibliography
  • 7.2. Abbreviations
  • 7.3. Definitions
  • 7.4. Methodology
  • 7.5. Coverage
  • 7.6. Primary Research
  • 7.7. Physicians and Specialists Included in this Study
  • 7.8. Secondary Research
  • 7.9. About the Authors
    • 7.9.1. Analysts
    • 7.9.2. Global Head of Healthcare
  • 7.10. About GlobalData
  • 7.11. Contact Us
  • 7.12. Disclaimer

List of Tables

  • Table 1: Ideal Bariatric Treatment Attributes
  • Table 2: Obesity Treatment Marketed Devices by Type
  • Table 3: Product Profile - End Ball
  • Table 4: End Ball SWOT Analysis
  • Table 5: Product Profile - Obalon
  • Table 6: Obalon SWOT Analysis
  • Table 7: Product Profile - Orbera
  • Table 8: Orbera SWOT Analysis
  • Table 9: Product Profile - Heliosphere
  • Table 10: Heliosphere SWOT Analysis
  • Table 11: Product Profile - ReShape Duo
  • Table 12: ReShape Duo SWOT Analysis
  • Table 13: Product Profile - SatiSphere
  • Table 14: SatiSphere SWOT Analysis
  • Table 15: Product Profile - Spatz
  • Table 16: Spatz SWOT Analysis
  • Table 17: Product Profile - Intraluminal Circular Stapler
  • Table 18: Intraluminal Stapler SWOT Analysis
  • Table 19: Product Profile - OverStitch
  • Table 20: Overstitch SWOT Analysis
  • Table 21: Product Profile - StomaphyX
  • Table 22: StomaphyX SWOT Analysis
  • Table 23: Product Profile - Abiliti
  • Table 24: Abiliti SWOT Analysis
  • Table 25: Product Profile - DIAMOND Tantalus
  • Table 26: DIAMOND Tantalus SWOT Analysis
  • Table 27: Product Profile - AspireAssist
  • Table 28: AspireAssist SWOT Analysis
  • Table 29: Product Profile - EndoBarrier
  • Table 30: EndoBarrier SWOT Analysis
  • Table 31: Product Profile - Vbloc Maestro System
  • Table 32: Maestro System with Vbloc SWOT Analysis
  • Table 33: Product Profile - AMI Band
  • Table 34: AMI Band SWOT Analysis
  • Table 35: Product Profile - Bioring
  • Table 36: Bioring SWOT Analysis
  • Table 37: Product Profile - Heliogast
  • Table 38: Heliogast SWOT Analysis
  • Table 39: Product Profile - Lap-Band
  • Table 40: Lap-Band SWOT Analysis
  • Table 41: Product Profile - Midband
  • Table 42: Midband SWOT Analysis
  • Table 43: Product Profile - MiniMizer
  • Table 44: MiniMizer SWOT Analysis
  • Table 45: Product Profile - Swedish/Realize Band
  • Table 46: Swedish/Realize Band SWOT Analysis
  • Table 47: Obesity Treatment Pipeline Devices by Type
  • Table 48: Product Profile - Full Sense Device
  • Table 49: Full Sense Device SWOT Analysis
  • Table 50: Product Profile - TransPyloric Shuttle
  • Table 51: TransPyloric Shuttle SWOT Analysis
  • Table 52: Product Profile - Deep Brain Stimulation Device
  • Table 53: Deep Brain Stimulation Device SWOT Analysis
  • Table 54: Product Profile - ACE Stapler
  • Table 55: ACE Stapler SWOT Analysis
  • Table 56: Product Profile - RS2 Restore
  • Table 57: RS2 Restore SWOT Analysis
  • Table 58: Product Profile - ValenTx
  • Table 59: ValenTx SWOT Analysis
  • Table 60: Product Profile - AMI B-Band
  • Table 61: AMI B-Band SWOT Analysis
  • Table 62: Product Profile - AMI Basket
  • Table 63: AMI Basket SWOT Analysis
  • Table 64: Product Profile - TERIS
  • Table 65: TERIS SWOT Analysis
  • Table 66: Company Profile - Allergan
  • Table 67: Allergan SWOT Analysis
  • Table 68: Company Profile - Apollo Endosurgery
  • Table 69: Apollo Endosurgery SWOT Analysis
  • Table 70: Company Profile - Aspire Bariatrics, Inc.
  • Table 71: Aspire Bariatrics, Inc. SWOT Analysis
  • Table 72: Company Profile - Agency for Medical Innovation
  • Table 73: Agency for Medical Innovation SWOT Analysis
  • Table 74: Company Profile - Bariatric Solutions
  • Table 75: Bariatric Solutions SWOT Analysis
  • Table 76: Company Profile - Baronova
  • Table 77: Baronova SWOT Analysis
  • Table 78: Company Profile - BaroSense, Inc.
  • Table 79: BaroSense, Inc. SWOT Analysis
  • Table 80: Company Profile - BFKW
  • Table 81: BFKW SWOT Analysis
  • Table 82: Company Profile - Cousin Biotech
  • Table 83: Cousin Biotech SWOT Analysis
  • Table 84: Company Profile - CR Bard
  • Table 85: CR Bard SWOT Analysis
  • Table 86: Company Profile - Endalis Laboratory
  • Table 87: Endalis Laboratory SWOT Analysis
  • Table 88: Company Profile - EndoGastric Solutions
  • Table 89: EndoGastric Solutions SWOT Analysis
  • Table 90: Company Profile - EndoSphere, Inc.
  • Table 91: EndoSphere, Inc. SWOT Analysis
  • Table 92: Company Profile - EnteroMedics, Inc.
  • Table 93: EnteroMedics, Inc. SWOT Analysis
  • Table 94: Company Profile - Ethicon Endo-Surgery
  • Table 95: Ethicon Endo-Surgery SWOT Analysis
  • Table 96: Company Profile - GI Dynamics
  • Table 97: GI Dynamics SWOT Analysis
  • Table 98: Company Profile - Helioscopie
  • Table 99: Helioscopie SWOT Analysis
  • Table 100: Company Profile - IntraPace Inc.
  • Table 101: IntraPace Inc. SWOT Analysis
  • Table 102: Company Profile - Medical Innovation Development
  • Table 103: Medical Innovation Development SWOT Analysis
  • Table 104: Company Profile - MetaCure, Inc.
  • Table 105: MetaCure, Inc. SWOT Analysis
  • Table 106: Company Profile - Obalon Therapeutics
  • Table 107: Obalon Therapeutics SWOT Analysis
  • Table 108: Company Profile - ReShape Medical
  • Table 109: ReShape Medical SWOT Analysis
  • Table 110: Company Profile - Spatz Medical
  • Table 111: Spatz Medical SWOT Analysis
  • Table 112: Company Profile - ValenTx, Inc.
  • Table 113: ValenTx, Inc. SWOT Analysis
Back to Top